Proceedings, Debates of the U.S. Congress
June 15, 2018
115th Congress, 2nd Session
Issue: Vol. 164, No. 100 — Daily Edition
Entire Issue (PDF)
Daily Digest Section (PDF)
Friday, June 15, 2018
The Senate was not in session and stands adjourned until 3 p.m., on Monday, June 18, 2018.
No committee meetings were held.
House of Representatives
Reports Filed: There were no reports filed today.
Speaker: Read a letter from the Speaker wherein he appointed Representative Bost to act as Speaker pro tempore for today.
Stop the Importation and Trafficking of Synthetic Analogues Act: The House passed H.R. 2851, to amend the Controlled Substances Act to clarify how controlled substance analogues are to be regulated, by a recorded vote of 239 ayes to 142 noes, Roll No. 268.
Pursuant to the Rule, it shall be in order to consider as an original bill for the purpose of amendment under the five-minute rule an amendment in the nature of a substitute consisting of the text of Rules Committee Print 115–74, in lieu of the amendment in the nature of a substitute recommended by the Committee on the Judiciary.
Griffith amendment (No. 1 printed in part A of H. Rept. 115–751) that incorporates an inter-agency agreement transmitted to Congress by the Office of National Drug Control Policy (ONDCP), the U.S. Department of Health and Human Services (HHS) and the U.S. Department of Justice (DOJ); clarifies when the Attorney General can temporarily and permanently schedule a drug or substance to the newly created schedule A and prevents the Attorney General from permanently scheduling that drug or substance if the Secretary of HHS determines that there is not sufficient potential for abuse; also clarifies under what circumstances an applicant for a schedule A registration may continue to conduct research with such schedule A substance while their application is pending, among their research accommodations;
Sean Patrick Maloney (NY) amendment (No. 3 printed in part A of H. Rept. 115–751) that requires the Drug Enforcement Administration to make available a report on controlled substance analogues sold by means of the internet; and
Thornberry amendment (No. 4 printed in part A of H. Rept. 115–751) that specifies the factors to determine whether a controlled substance analogue is intended for human consumption, thus making it easier for law enforcement and health officials to take action against synthetic drug manufacturers, distributors, and sellers (by a recorded vote of 223 ayes to 158 noes, Roll No. 267).
Meeting Hour: Agreed by unanimous consent that when the House adjourns today, it adjourn to meet at 12 noon on Tuesday, June 19th for Morning Hour debate.
Adjournment: The House met at 9 a.m. and adjourned at 11:38 a.m.
Committee on Appropriations: Subcommittee on Labor, Health and Human Services, Education, and Related Agencies held a markup on the FY 2019 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill. The FY 2019 Labor, Health and Human Services, Education, and Related Agencies Appropriations Bill was forwarded to the full Committee, without amendment.
THE STATE OF U.S. PUBLIC HEALTH BIOPREPAREDNESS: RESPONDING TO BIOLOGICAL ATTACKS, PANDEMICS, AND EMERGING INFECTIOUS DISEASE OUTBREAKS
Committee on Energy and Commerce: Subcommittee on Oversight and Investigations held a hearing entitled ``The State of U.S. Public Health Biopreparedness: Responding to Biological Attacks, Pandemics, and Emerging Infectious Disease Outbreaks''. Testimony was heard from the following Department of Health and Human Services officials: Rick A. Bright, Director, Biomedical Advanced Research and Development Authority, and Deputy Assistant Secretary, Office of the Assistant Secretary for Preparedness and Response; Anthony Fauci, Director, National Institute of Allergy and Infectious Diseases, National Institutes of Health; Rear Admiral Denise Hinton, Chief Scientist, U.S. Food and Drug Administration; and Anne Schuchat, Principal Deputy Director, Centers for Disease Control and Prevention.
TRUMP ADMINISTRATION'S RUSSIA POLICY
Commission on Security and Cooperation in Europe: Commission received a briefing on the Trump Administration's Russia policy from Herman Pirchner, Jr., American Foreign Policy Council, and Alina Polyakova, Brookings Institution, both of Washington, D.C.; and Yulia Latynina, Echo Moskvy and Novaya Gazeta, Moscow, Russia.
Committee on the Judiciary: to hold hearings to examine the Inspector General's first report on Department of Justice and Federal Bureau of Investigation actions in advance of the 2016 presidential election, 2 p.m., SH–216.
No hearings are scheduled.
Commission on Security and Cooperation in Europe: to receive a briefing on corruption in Ukraine's energy sector, 3:30 p.m., SD–G11.
Program for Monday: Senate will resume consideration of H.R. 5515, National Defense Authorization Act, post-cloture, and vote on a motion to waive a budget point of order thereon, followed by a vote on passage of the bill, at 5:30 p.m.
Following disposition of H.R. 5515, Senate will vote on the motion to invoke cloture on the motion to proceed to consideration of H.R. 5895, Energy and Water, Legislative Branch, and Military Construction and Veterans Affairs Appropriations Act.
Program for Tuesday: To be announced.
Connolly, Gerald E., Va., E854
Crowley, Joseph, N.Y., E850
Cuellar, Henry, Tex., E851
Dingell, Debbie, Mich., E852
Faso, John J., N.Y., E853
Gianforte, Greg, Mont., E849
Gonzalez, Vicente, Tex., E850
Graves, Garret, La., E842
Neal, Richard E., Mass., E851
Norton, Eleanor Holmes, The District of Columbia, E855
Vela, Filemon, Tex., E850
Wilson, Joe, S.C., E852